HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased serum HMGB1 is related to the severity of coronary artery stenosis.

AbstractBACKGROUND:
High mobility group box 1 (HMGB1) protein has been identified as a novel pro-inflammatory cytokine in coronary artery disease (CAD). We investigated the relationship between serum HMGB1 level and the severity of coronary artery stenosis.
METHODS:
Serum HMGB1 concentration in patients was measured by ELISA. All patients underwent coronary angiography and were assigned into groups according to the quartile of HMGB1 level.
RESULTS:
HMGB1 level in USAP group was higher than that in control and SAP group. HMGB1 level in SAP group was higher than that in control group (p<0.05). Gensini scores in the highest quartile group (group IV), group III and group II were all significantly higher than that in the lowest quartile group (group I). There was significant correlation between angiographic Gensini score and serum level of HMGB1 (r=0.710, p<0.05). However, in subgroup analysis, we found that serum HMGB1 level was only correlated with angiographic Gensini score in SAP patients (r=0.786, p<0.05), but not USAP patients.
CONCLUSIONS:
Serum HMGB1 level was markedly increased with the severity of coronary artery stenosis in patients with SAP and USAP, especially in SAP patients, which suggested that increased serum HMGB1 may involve in the pathogenesis of atherosclerotic CAD.
AuthorsXiaorong Hu, Hong Jiang, Qijun Bai, Xiaoya Zhou, Changwu Xu, Zhibing Lu, Bo Cui, Huazhi Wen
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 406 Issue 1-2 Pg. 139-42 (Aug 2009) ISSN: 1873-3492 [Electronic] Netherlands
PMID19545550 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HMGB1 Protein
Topics
  • Adult
  • Aged
  • Angina, Unstable (blood, complications)
  • Coronary Stenosis (blood, complications)
  • Female
  • HMGB1 Protein (blood)
  • Humans
  • Linear Models
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: